Desq Long
Sign in

Company

AN2 Therapeutics, Inc.

ANTX · CIK 0001880438

SEC FORM 4
$0.00

AN2 Therapeutics, Inc. (ANTX)

Acquisition (code A) of 116,667 shares at $0 per share.

Reporting Person Trenor Cameron C. III · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001193125-26-393274 · filed 2026-09-16 · View filing →

SEC FORM 4
$3,150.71

AN2 Therapeutics, Inc. (ANTX)

Sale of 523 shares at $6.0243 per share.

Reporting Person Readnour Robin Shane · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001193125-26-389545 · filed 2026-09-11 · View filing →

SEC FORM 4
$3,524.22

AN2 Therapeutics, Inc. (ANTX)

Sale of 585 shares at $6.0243 per share.

Reporting Person Readnour Robin Shane · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001193125-26-389545 · filed 2026-09-11 · View filing →

SEC FORM 4
$28,436.47

AN2 Therapeutics, Inc. (ANTX)

Sale of 4,725 shares at $6.0183 per share.

Reporting Person Readnour Robin Shane · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001193125-26-385511 · filed 2026-09-08 · View filing →

SEC FORM 4
$31,860.88

AN2 Therapeutics, Inc. (ANTX)

Sale of 5,294 shares at $6.0183 per share.

Reporting Person Readnour Robin Shane · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001193125-26-385511 · filed 2026-09-08 · View filing →

SEC FORM 4
$17,462.81

AN2 Therapeutics, Inc. (ANTX)

Sale of 2,877 shares at $6.0698 per share.

Reporting Person Readnour Robin Shane · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001193125-26-385511 · filed 2026-09-08 · View filing →

SEC FORM 4
$19,562.97

AN2 Therapeutics, Inc. (ANTX)

Sale of 3,223 shares at $6.0698 per share.

Reporting Person Readnour Robin Shane · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001193125-26-385511 · filed 2026-09-08 · View filing →

SEC FORM 4
$1,504.16

AN2 Therapeutics, Inc. (ANTX)

Sale of 272 shares at $5.53 per share.

Reporting Person Williams Sarah Joanne · Officer Title Principal Accounting Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 4, 2026FILED +3 DAYS

Source: SEC Form 4 · 0001193125-26-383697 · filed 2026-09-04 · View filing →

SEC FORM 4
$11,601.94

AN2 Therapeutics, Inc. (ANTX)

Purchase of 2,098 shares at $5.53 per share.

Reporting Person FitzPatrick Margaret M · Transaction Code P

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-380595 · filed 2026-09-02 · View filing →

SEC FORM 4
$100,312.91

AN2 Therapeutics, Inc. (ANTX)

Sale of 16,696 shares at $6.0082 per share.

Reporting Person Readnour Robin Shane · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001193125-26-357225 · filed 2026-08-19 · View filing →

SEC FORM 4
$112,389.39

AN2 Therapeutics, Inc. (ANTX)

Sale of 18,706 shares at $6.0082 per share.

Reporting Person Readnour Robin Shane · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001193125-26-357225 · filed 2026-08-19 · View filing →